Inflarx Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$2.24

-0.04 (-1.75%)

As of Jun 30, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +167.9% upside

Low Target $4.29

Average Target $6.00

High Target $7.91

Current Price $2.24

Current
$2.24

Target
$6.00

$4.29 $6.00 avg $7.91

Scenario Analysis

Bear Case

$4.29

91.5%

Low target

Base Case

$6.00

+167.9%

Avg target

Bull Case

$7.91

+253.1%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$2.95

-24.0% from high

52-Week Low

$0.74

+202.5% from low

Target vs 52W High

$6.00

+103.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%